You will be redirected to https://www.worldscientific.com/apbn to view or purchase the issue PDF.
Industry Watch • AustCancer Completes US Cancer Care Acquisition • Biota-Sankyo in Influenza Drug Partnership • Eastland Files Patent for Rota-Vax • GTG Commercializes Genetic Test for Athletic Performance • Meridica Licenses Xcelovair™ to Pfizer • Avesthagen Sets Up US Subsidiaries • Nicholas Piramal Hunting for Global Partners and Researchers in Therapeutic R&D • Cipla Exerts Its Presence in US Market • Unichem's Expansion Plans • Takeda Sues Mylan, Watson abd Ranbaxy over Patent Infringements • Yamanouchi's Vesicare Receives USFDA Approval for Launch • TaiGen and TTY Biopharm Co-develop Cancer Treatment Drug
Products/Services Highlight • New Radiotherapy Center in Australia • Breakthrough in Cardiac Disease Treatment • New Prostheses Available in Taiwan
Research Findings • Arthron's Proprietary Target Identified as TNFá Regulator • Glaucoma - A Growing Concern for Japanese
Rules & Regulations • Indian Government Retains Ban on Phase I Drug Trial
Agriculture • Increased Popularity of Food Labels among Consumers • Biotechnology Offers Solutions for Sustaining Agricultural Growth • Avestha Gengraine Granted Patent for New Transgenic Technology • Controversy over Regulation of Bt Cotton • Japan Prefers Taiwanese Agricultural Produce
General News • Australia Embarks on New Biotech Strategy • India Formulates Framework Telemedicine • India Emerging as Global Clinical Trial Center • Indonesia's Policy for Biotechnology • Genetic Diagnosis for In Vitro Fertilized Egg Planned • Initatives to Boost New Zealand's Biotechnology
Global Development • Procyon Secures Patent for Novel Anti-HIV Protease Inhibitors
Conference Calendar